BRIEF published on 08/28/2025 at 18:56, 7 months 3 days ago Bilan semestriel 2025 d'ABIONYX Pharma Chiffre D'affaires Trésorerie ABIONYX Pharma Soutien Financier Semestre 2025
BRIEF published on 08/28/2025 at 18:56, 7 months 3 days ago ABIONYX Pharma 2025 half-year review Treasury Financial Support Turnover ABIONYX Pharma Semester 2025
PRESS RELEASE published on 08/28/2025 at 18:51, 7 months 3 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma fait le point sur son activité et sa trésorerie du 1er semestre 2025, notamment un chiffre d'affaires de 2,1 M€ provenant de sa filiale IRIS Pharma. La trésorerie s'établit à 3,4 M€ Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma Thérapies Innovantes
PRESS RELEASE published on 08/28/2025 at 18:51, 7 months 3 days ago Inside Information / Other news releases ABIONYX Pharma provided an update on its activity and cash position for Q2 2025. Company's revenue, cash position, and government funding details revealed Revenue Cash Position Update Government Funding ABIONYX Pharma
BRIEF published on 08/27/2025 at 19:31, 7 months 4 days ago ABIONYX Pharma en pourparlers pour un partenariat stratégique dans le sepsis Partenariat Stratégique ABIONYX Pharma Sepsis CER-001 Thérapies Innovantes
BRIEF published on 08/27/2025 at 19:31, 7 months 4 days ago ABIONYX Pharma in talks for a strategic partnership in sepsis Strategic Partnership Innovative Therapies ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 08/27/2025 at 19:26, 7 months 4 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce des discussions avec un acteur majeur du sepsis pour un partenariat stratégique. L'entreprise vise à accélérer le développement de CER-001 dans le sepsis Développement Partenariat Stratégique ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 08/27/2025 at 19:26, 7 months 4 days ago Inside Information / Other news releases ABIONYX Pharma initiates discussions with a major sepsis player for strategic partnership, aiming to accelerate CER-001 development. Relevance of innovative technology validated Strategic Partnership Innovative Technology ABIONYX Pharma Sepsis CER-001
BRIEF published on 08/21/2025 at 23:20, 7 months 10 days ago ABIONYX : Structure du capital et droits de vote au 31 juillet 2025 Euronext Paris Droits De Vote Capital Social Actions ABIONYX
BRIEF published on 08/21/2025 at 23:20, 7 months 10 days ago ABIONYX: Capital structure and voting rights as of July 31, 2025 Euronext Paris Share Capital Voting Rights Actions ABIONYX
Published on 04/01/2026 at 17:50, 22 minutes ago Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform
Published on 04/01/2026 at 17:00, 1 hour 12 minutes ago Stagwell Announces UNICEPTA UK and Hootsuite Strategic Partnership to Deliver Decision-Grade Media Intelligence Within the Talkwalker Platform
Published on 04/01/2026 at 16:00, 2 hours 12 minutes ago Norsemont Commences Trading on the OTCQX Market
Published on 04/01/2026 at 15:10, 3 hours 2 minutes ago A2Z Announces Audited Full-Year 2025 Financial Results
Published on 04/01/2026 at 15:00, 3 hours 12 minutes ago Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers
Published on 04/01/2026 at 18:05, 6 minutes ago Mutares approves capital increase with subscription rights to accelerate growth through aggressive expansion in the U.S.
Published on 04/01/2026 at 17:59, 12 minutes ago SFS acquires German supplier of fastening systems for flat roofs
Published on 04/01/2026 at 17:55, 16 minutes ago EQS-Adhoc: Mutares SE & Co. KGaA resolves to implement a capital increase with subscription rights against cash contribution with pre-placement to institutional investors
Published on 04/01/2026 at 17:48, 24 minutes ago HBM Healthcare Investments increases NAV by 17.2 percent and expects annual profit of CHF 272 million for the 2025/2026 financial year
Published on 04/01/2026 at 18:02, 9 minutes ago CP MOULINVEST : TRANSFERT DU CONTRAT DE LIQUIDITE AUPRES DE TPICAP
Published on 04/01/2026 at 18:00, 12 minutes ago Closing of acquisition of Chaplin's World operating company
Published on 04/01/2026 at 18:00, 12 minutes ago Finalisation de l'acquisition de la société d'exploitation de Chaplin's World
Published on 04/01/2026 at 18:00, 12 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 04/01/2026 at 18:00, 12 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
